Case Reports: Exposure to SARS-CoV-2, Acute Kidney Injury, and Lithium Toxicity.
J Clin Psychopharmacol
; 42(5): 461-463, 2022.
Article
in English
| MEDLINE | ID: covidwho-1973302
ABSTRACT
PURPOSES:
The aims of the study were to review 3 cases of lithium toxicity among individuals with bipolar disorder who were diagnosed with COVID-19 and to review the literature discussing the implications of COVID-19 and exposure to SARS-CoV-2 relative to medical use of lithium in management of bipolar disorder.METHODS:
This is a case review of medical and psychiatric notes of 3 individuals with bipolar disorder, managed with lithium, who developed COVID-19. This study discussed these cases in context of previous case reports and relevant literature pertaining to lithium and exposure to SARS-CoV-2.FINDINGS:
Infection with SARS-CoV-2 along with symptoms of COVID-19 and mental state changes in three individuals were temporally associated with lithium levels in the toxic range. IMPLICATIONS Exposure to SARS-CoV-2 or symptoms suggestive of COVID-19 should result in increased clinical monitoring of individuals taking lithium. Those taking lithium and providers are advised to have a low clinical threshold for requesting lithium levels and kidney function estimates for the duration of the COVD-19 pandemic.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Acute Kidney Injury
/
COVID-19
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
J Clin Psychopharmacol
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS